文献速递核素与放射性配体治疗

基于混合[99mTc]Tc-MAA SPECT/ceCT的放射性栓塞治疗计划新方法

A novel approach to radioembolization treatment planning using a hybrid [99mTc]Tc-MAA contrast enhanced SPECT/CT.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-07-11

本研究在24例肝细胞癌患者中比较常规工作流与直接于SPECT/ceCT上勾画的混合工作流的剂量学差异,发现混合工作流使索引病灶剂量升高6%、正常组织剂量降低11%,索引病灶剂量与体积在两种工作流间差异显著。

要点

  • 混合SPECT/ceCT直接勾画技术上可行,索引病灶剂量较常规工作流高6%。
  • 混合工作流正常组织剂量较常规工作流低11%。
  • 索引病灶剂量(p=0.01)与体积(p=0.01)在两种工作流间差异显著。

核心结论

  • 混合[99mTc]Tc-MAA SPECT/ceCT治疗计划技术可行,且与常规方法相比剂量学指标存在显著差异。

研究设计与样本

  • 在24例肝细胞癌患者中实施混合SPECT/ceCT,并分别按常规工作流与混合工作流制定治疗计划。
  • 使用Simplicit90Y与SurePlan Liver Y90软件量化两种工作流体积间的剂量学与位置差异。
  • 采用Bland-Altman分析与轮廓比对指数评价结果。

主要发现

  • 直接于SPECT/ceCT勾画使索引病灶剂量升高6%(均值19.5 Gy,95%LoA:-43.9 Gy至83.0 Gy)。
  • 直接于SPECT/ceCT勾画使正常组织剂量降低11%(均值-17.6 Gy,95%LoA:-104.4 Gy至69.3 Gy)。
  • 基线CT与SPECT/ceCT间索引病灶体积增加14%(95%LoA:-55.9%至82.9%)。
  • 索引病灶剂量(p=0.01)与体积(p=0.01)在两种工作流间差异显著。
  • 基线影像与SPECT/ceCT的中位时间间隔为6周(IQR:3.7至9.3周),索引病灶中位偏差4.9±2.2 mm,平均DICE评分0.6±0.2。

关键数值与推荐

  • 指南推荐在基线ceCT上分割体积并配准至SPECT/低剂量CT,但该常规方法易受空间配准误差与疾病进展影响。

临床怎么用

  • 可考虑在SPECT/ceCT上直接勾画以制定放射性栓塞治疗计划,但需注意其与常规工作流剂量学结果的显著差异。

局限性

  • 样本量24例,研究结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dosimetry-guided treatment planning is central to radioembolization. Guidelines recommend segmenting volumes on baseline contrast-enhanced CT (ceCT) and registering to a SPECT/low-dose CT. However, this conventional approach is vulnerable to spatial misregistration and potential disease progression. This study evaluates a hybrid SPECT/ceCT-based planning methodology, hypothesising that it yields significantly different dosimetry metrics compared to the conventional workflow. MATERIALS AND METHODS: Hybrid SPECT/ceCT was performed in 24 patients with hepatocellular carcinoma. Treatment planning followed both the conventional and hybrid workflow, where delineation was performed directly on SPECT/ceCT. Quantification of dosimetric and positional differences between volumes from the two workflows was performed using Simplicit90Y (Mirada Medical) and SurePlan Liver Y90 (MIM) software, respectively. Outcomes were evaluated by Bland-Altman analysis and contour intercomparison indices. RESULTS: Direct delineation on SPECT/ceCT yielded higher index lesion (largest single tumour) doses (6% increased) (mean: 19.5 Gy, 95% limits of agreement [LoA]: -43.9 Gy, 83.0 Gy) and lower normal tissue doses (11% decrease) (mean: -17.6 Gy 95% LoA: -104.4 Gy, 69.3 Gy). Index lesion volume increase between baseline CT and SPECT/ceCT was 14% (95% LoA: -55.9%, 82.9%). Index lesion dose (p = 0.01) and volume (p = 0.01) differed significantly between workflows. The median time interval between baseline imaging and SPECT/ceCT was 6 weeks (IQR: 3.7 to 9.3 weeks). The median deviation of the index lesion between the baseline diagnostic image and hybrid SPECT/ceCT image was 4.9 ± 2.2 mm and there was an average DICE score of 0.6 ± 0.2. CONCLUSION: Hybrid [99mTc]Tc-MAA SPECT/ceCT treatment planning is technically feasible and leads to significant differences in dosimetry metrics compared with the conventional method.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Keane G, Lam MGEH, Smits MLJ, et al. A novel approach to radioembolization treatment planning using a hybrid [99mTc]Tc-MAA contrast enhanced SPECT/CT. Eur J Nucl Med Mol Imaging. 2026. PMID: 42435201. doi:10.1007/s00259-026-08027-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。